Insider Transactions in Q1 2022 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,666
-43.96%
|
$5,117,266
$101.84 P/Share
|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
47,375
+29.13%
|
-
|
|
Jan 05
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,822
+49.61%
|
-
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
41,276
-23.32%
|
$4,168,876
$101.84 P/Share
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
32,301
+15.43%
|
-
|
|
Jan 05
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
53,734
+27.08%
|
-
|
|
Jan 05
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,030
-24.94%
|
$710,030
$101.84 P/Share
|
|
Jan 05
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,999
+33.18%
|
-
|
|
Jan 05
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,710
-30.72%
|
$2,192,710
$101.84 P/Share
|
|
Jan 05
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,839
+40.87%
|
-
|
|
Jan 05
2022
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,175
-14.92%
|
$825,675
$101.84 P/Share
|
|
Jan 05
2022
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,289
+25.02%
|
-
|